Takeda Pharmaceuticals International AG Ireland Branch
- A06 - Agentes contra el estreñimiento
- RESOLOR film-coated tablet 1 mg
- RESOLOR film-coated tablet 2 mg
- A16 - Otros productos para el tracto alimentario y metabolismo
- ELAPRASE concentrate for solution for infusion 2 mg/ml
- REPLAGAL concentrate for solution for infusion 1 mg/ml
- REVESTIVE powder and solvent for solution for injection 1.25 mg
- REVESTIVE powder and solvent for solution for injection 5 mg
- VPRIV powder for solution for infusion 400 IU
- B06 - Otros agentes hematológicos
- FIRAZYR U?PILDYTAME ?VIRK?TE solution for injection 30 mg
- TAKHZYRO PREFILLED SYRINGE solution for injection 300 mg
- TAKHZYRO solution for injection 300 mg
- C02 - Antihipertensivos
- INTUNIV prolonged-release tablet 1 mg
- INTUNIV prolonged-release tablet 2 mg
- INTUNIV prolonged-release tablet 3 mg
- INTUNIV prolonged-release tablet 4 mg
- H02 - Corticosteroides para uso sistémico
- PLENADREN modified-release tablet 20 mg
- PLENADREN modified-release tablet 5 mg
- H05 - Homeostasis del calcio
- NATPAR powder and solvent for solution for injection 100 µg/dose
- NATPAR powder and solvent for solution for injection 25 µg/dose
- NATPAR powder and solvent for solution for injection 50 µg/dose
- NATPAR powder and solvent for solution for injection 75 µg/dose
- J05 - Antivirales de uso sistémico
- LIVTENCITY film-coated tablet 200 mg
- L01 - Antineoplásicos
- XAGRID capsule, hard 0.5 mg
- V03 - Todos los demás preparados terapéuticos
- FOSRENOL chewable tablet 1 000 mg
- FOSRENOL chewable tablet 250 mg
- FOSRENOL chewable tablet 500 mg
- FOSRENOL chewable tablet 750 mg